Get the Stockscreener App
13.49
1.66%
0.22
Pre-market:
13.75
0.26
+1.93%
Pulse Biosciences Inc stock is traded at $13.49, with a volume of 146.84K.
It is up +1.66% in the last 24 hours and down -12.74% over the past month.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
See More
Previous Close:
$13.27
Open:
$13.32
24h Volume:
146.84K
Relative Volume:
0.79
Market Cap:
$914.18M
Revenue:
$-9,000
Net Income/Loss:
$-68.03M
P/E Ratio:
-12.85
EPS:
-1.05
Net Cash Flow:
$-44.76M
1W Performance:
+1.81%
1M Performance:
-12.74%
6M Performance:
-21.11%
1Y Performance:
-31.70%
1-Day Range:
$13.20
$13.88
1-Week Range:
$12.95
$13.96
52-Week Range:
$12.56
$25.00
Pulse Biosciences Inc Stock (PLSE) Company Profile
Name
Pulse Biosciences Inc
Sector
Industry
Phone
510-906-4600
Address
3957 POINT EDEN WAY, HAYWARD, CA
Compare PLSE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
13.49 | 899.28M | -9,000 | -68.03M | -44.76M | -1.05 |
|
ISRG
Intuitive Surgical Inc
|
566.89 | 203.96B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
189.50 | 55.36B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.87 | 39.65B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
250.04 | 37.45B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
269.08 | 20.16B | 2.96B | 487.70M | 344.00M | 6.6758 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Initiated | Oppenheimer | Outperform |
| Jul-27-21 | Initiated | Stephens | Overweight |
| Mar-11-21 | Initiated | Maxim Group | Buy |
| Jan-26-21 | Reiterated | H.C. Wainwright | Buy |
| May-12-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-14-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Feb-25-19 | Initiated | H.C. Wainwright | Buy |
View All
Pulse Biosciences Inc Stock (PLSE) Latest News
Pulse Biosciences (PLSE) Collaborates with MD Anderson for Thyro - GuruFocus
Pulse Biosciences to begin thyroid cancer treatment study in 2026 By Investing.com - Investing.com Australia
Pulse Biosciences (Nasdaq: PLSE) gets FDA IDE nod for first thyroid cancer nPulse study - Stock Titan
With 73% ownership, insiders at Pulse Biosciences, Inc. (NASDAQ:PLSE) are pretty optimistic and have been buying recently - Yahoo Finance
Is Pulse Biosciences Inc. stock a buy before product launchesDollar Strength & AI Enhanced Trading Alerts - Newser
Bull Run: Is Pulse Biosciences Inc stock near bottom after declineJuly 2025 Retail & Stock Portfolio Risk Management - BỘ NỘI VỤ
How cyclical is Pulse Biosciences Inc. (6L8) stock compared to rivalsRecession Risk & Weekly High Return Forecasts - Newser
Is Pulse Biosciences Inc. stock a safe investment in uncertain markets2025 Institutional Moves & Real-Time Volume Analysis - Newser
Trading Systems Reacting to (PLSE) Volatility - news.stocktradersdaily.com
Is Pulse Biosciences Inc. stock a defensive play in 2025Trade Volume Report & Safe Entry Zone Identification - Newser
Is Pulse Biosciences Inc. stock near bottom after declineDay Trade & Reliable Breakout Stock Forecasts - Newser
Will Pulse Biosciences Inc. (6L8) stock benefit from Fed rate cutsVolume Spike & Community Trade Idea Sharing - Newser
How dovish Fed policy supports Pulse Biosciences Inc. (6L8) stockJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - Newser
Pulse Biosciences (PLSE) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Will Pulse Biosciences Inc. (6L8) stock benefit from mergersJuly 2025 Selloffs & Consistent Income Trade Ideas - Newser
Value Recap: Can Pulse Biosciences Inc. stock beat market expectations this quarter - moha.gov.vn
Operating cash flow per share of Pulse Biosciences, Inc. – SWB:6L8 - TradingView
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)November 21, 2025 - BioSpace
How Pulse Biosciences Inc (PLSE) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Pulse Biosciences announces inducement grants under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Is Pulse Biosciences Inc. (6L8) stock in buy zone after pullbackJuly 2025 Sector Moves & Breakout Confirmation Alerts - newser.com
Is Pulse Biosciences Inc. stock supported by innovation pipelineJuly 2025 Reactions & Real-Time Stock Movement Alerts - newser.com
Will Pulse Biosciences Inc. stock maintain momentum in 20252025 Performance Recap & Real-Time Volume Analysis - newser.com
Top chart patterns to watch in Pulse Biosciences Inc.July 2025 Price Swings & High Conviction Trade Alerts - newser.com
How high can Pulse Biosciences Inc. stock goJuly 2025 Macro Moves & Weekly High Return Opportunities - newser.com
What recovery options are there for Pulse Biosciences Inc.Entry Point & Free AI Powered Buy and Sell Recommendations - newser.com
Can Pulse Biosciences Inc. (6L8) stock resist broad market declinesWatch List & Growth Focused Entry Point Reports - newser.com
Why hedge funds are buying Pulse Biosciences Inc. stockJuly 2025 Action & High Accuracy Trade Signal Alerts - newser.com
Will Pulse Biosciences Inc. (6L8) stock draw ESG focused fundsTrend Reversal & Daily Volume Surge Signals - newser.com
Why Pulse Biosciences Inc. (6L8) stock benefits from AI revolutionEarnings Risk Report & Risk Managed Investment Entry Signals - newser.com
Is Pulse Biosciences Inc. stock positioned for digital transformation2025 Earnings Impact & Low Volatility Stock Recommendations - newser.com
Real time alert setup for Pulse Biosciences Inc. performanceMarket Movement Recap & Low Risk Investment Opportunities - newser.com
Using fundamentals and technicals on Pulse Biosciences Inc.Analyst Downgrade & Consistent Return Strategy Ideas - newser.com
Is Pulse Biosciences Inc. (6L8) stock considered safe haven2025 Short Interest & Fast Moving Trade Plans - newser.com
Pulse Biosciences Inc Stock (PLSE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pulse Biosciences Inc Stock (PLSE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Danahy Kevin Patrick | Chief Commercial Officer |
Oct 02 '25 |
Sale |
18.53 |
4,600 |
85,238 |
43,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Sep 18 '25 |
Option Exercise |
1.53 |
20,000 |
30,600 |
63,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Sep 19 '25 |
Option Exercise |
1.53 |
400 |
612 |
43,698 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Sep 18 '25 |
Sale |
18.49 |
20,000 |
369,800 |
43,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Sep 19 '25 |
Sale |
18.48 |
400 |
7,392 |
43,298 |
| UECKER DARRIN | Chief Technology Officer |
Sep 17 '25 |
Option Exercise |
4.00 |
181,534 |
726,136 |
284,406 |
| UECKER DARRIN | Chief Technology Officer |
Sep 16 '25 |
Option Exercise |
4.00 |
25,000 |
100,000 |
147,872 |
| UECKER DARRIN | Chief Technology Officer |
Sep 16 '25 |
Sale |
16.28 |
25,000 |
407,000 |
122,872 |
| UECKER DARRIN | Chief Technology Officer |
Sep 17 '25 |
Sale |
16.21 |
20,000 |
324,200 |
122,872 |
2.05%
0.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):